120 related articles for article (PubMed ID: 23415961)
1. Screening for potential targets for therapy in mesenchymal, clear cell, and dedifferentiated chondrosarcoma reveals Bcl-2 family members and TGFβ as potential targets.
van Oosterwijk JG; Meijer D; van Ruler MA; van den Akker BE; Oosting J; Krenács T; Picci P; Flanagan AM; Liegl-Atzwanger B; Leithner A; Athanasou N; Daugaard S; Hogendoorn PC; Bovée JV
Am J Pathol; 2013 Apr; 182(4):1347-56. PubMed ID: 23415961
[TBL] [Abstract][Full Text] [Related]
2. Genetic characterization of mesenchymal, clear cell, and dedifferentiated chondrosarcoma.
Meijer D; de Jong D; Pansuriya TC; van den Akker BE; Picci P; Szuhai K; Bovée JV
Genes Chromosomes Cancer; 2012 Oct; 51(10):899-909. PubMed ID: 22674453
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Bcl-2 family members sensitizes mesenchymal chondrosarcoma to conventional chemotherapy: report on a novel mesenchymal chondrosarcoma cell line.
de Jong Y; van Maldegem AM; Marino-Enriquez A; de Jong D; Suijker J; Briaire-de Bruijn IH; Kruisselbrink AB; Cleton-Jansen AM; Szuhai K; Gelderblom H; Fletcher JA; Bovée JV
Lab Invest; 2016 Oct; 96(10):1128-37. PubMed ID: 27617402
[TBL] [Abstract][Full Text] [Related]
4. Dedifferentiated peripheral chondrosarcomas: regulation of EXT-downstream molecules and differentiation-related genes.
Rozeman LB; de Bruijn IH; Bacchini P; Staals EL; Bertoni F; Bovée JV; Hogendoorn PC
Mod Pathol; 2009 Nov; 22(11):1489-98. PubMed ID: 19734846
[TBL] [Abstract][Full Text] [Related]
5. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
[TBL] [Abstract][Full Text] [Related]
6. The clinical approach towards chondrosarcoma.
Gelderblom H; Hogendoorn PC; Dijkstra SD; van Rijswijk CS; Krol AD; Taminiau AH; Bovée JV
Oncologist; 2008 Mar; 13(3):320-9. PubMed ID: 18378543
[TBL] [Abstract][Full Text] [Related]
7. Peripheral chondrosarcoma progression is accompanied by decreased Indian Hedgehog signalling.
Hameetman L; Rozeman LB; Lombaerts M; Oosting J; Taminiau AH; Cleton-Jansen AM; Bovée JV; Hogendoorn PC
J Pathol; 2006 Aug; 209(4):501-11. PubMed ID: 16755518
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of HER-2/neu status by real-time quantitative PCR in malignant cartilaginous tumors.
Park HR; Kim YW; Jung WW; Kim HS; Unni KK; Park YK
Int J Oncol; 2004 Mar; 24(3):575-80. PubMed ID: 14767542
[TBL] [Abstract][Full Text] [Related]
9. ABT-737 resistance in B-cells isolated from chronic lymphocytic leukemia patients and leukemia cell lines is overcome by the pleiotropic kinase inhibitor quercetin through Mcl-1 down-regulation.
Russo M; Spagnuolo C; Volpe S; Tedesco I; Bilotto S; Russo GL
Biochem Pharmacol; 2013 Apr; 85(7):927-36. PubMed ID: 23353698
[TBL] [Abstract][Full Text] [Related]
10. Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma.
de Jong Y; Monderer D; Brandinelli E; Monchanin M; van den Akker BE; van Oosterwijk JG; Blay JY; Dutour A; Bovée JVMG
Oncogenesis; 2018 Sep; 7(9):74. PubMed ID: 30242253
[TBL] [Abstract][Full Text] [Related]
11. The use of Bcl-2 and PTHLH immunohistochemistry in the diagnosis of peripheral chondrosarcoma in a clinicopathological setting.
Hameetman L; Kok P; Eilers PH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
Virchows Arch; 2005 Apr; 446(4):430-7. PubMed ID: 15744499
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal chondrosarcoma: molecular characterization by a proteomic approach, with morphogenic and therapeutic implications.
Brown RE; Boyle JL
Ann Clin Lab Sci; 2003; 33(2):131-41. PubMed ID: 12817616
[TBL] [Abstract][Full Text] [Related]
13. Matrix biochemistry and cell biology of dedifferentiated chondrosarcomas.
Dornauer K; Söder S; Inwards CY; Bovee JV; Aigner T
Pathol Int; 2010 May; 60(5):365-72. PubMed ID: 20518886
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship studies of ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA 14-1), an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancer.
Doshi JM; Tian D; Xing C
J Med Chem; 2006 Dec; 49(26):7731-9. PubMed ID: 17181155
[TBL] [Abstract][Full Text] [Related]
15. Expression of ezrin, Bcl-2, and Ki-67 in chondrosarcomas.
Söderström M; Palokangas T; Vahlberg T; Böhling T; Aro H; Carpen O
APMIS; 2010 Oct; 118(10):769-76. PubMed ID: 20854471
[TBL] [Abstract][Full Text] [Related]
16. H-ras oncogene mutation in dedifferentiated chondrosarcoma: polymerase chain reaction-restriction fragment length polymorphism analysis.
Sakamoto A; Oda Y; Adachi T; Oshiro Y; Tamiya S; Tanaka K; Matsuda S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2001 Apr; 14(4):343-9. PubMed ID: 11301351
[TBL] [Abstract][Full Text] [Related]
17. siRNA-based targeting of antiapoptotic genes can reverse chemoresistance in P-glycoprotein expressing chondrosarcoma cells.
Kim DW; Kim KO; Shin MJ; Ha JH; Seo SW; Yang J; Lee FY
Mol Cancer; 2009 May; 8():28. PubMed ID: 19445670
[TBL] [Abstract][Full Text] [Related]
18. BH3 mimetic ABT-737 neutralizes resistance to FLT3 inhibitor treatment mediated by FLT3-independent expression of BCL2 in primary AML blasts.
Kohl TM; Hellinger C; Ahmed F; Buske C; Hiddemann W; Bohlander SK; Spiekermann K
Leukemia; 2007 Aug; 21(8):1763-72. PubMed ID: 17554384
[TBL] [Abstract][Full Text] [Related]
19. Expression of plasminogen activators and plasminogen activator inhibitor 1 in dedifferentiated chondrosarcoma.
Häckel C; Czerniak B; Ayala AG; Radig K; Roessner A
Cancer; 1997 Jan; 79(1):53-8. PubMed ID: 8988726
[TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, NCC-dCS1-C1.
Oyama R; Kito F; Takahashi M; Sakumoto M; Shiozawa K; Qiao Z; Noguchi R; Kubo T; Toki S; Nakatani F; Yoshida A; Kawai A; Kondo T
Hum Cell; 2019 Apr; 32(2):202-213. PubMed ID: 30737713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
